NCT02106000 A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour Status COMPLETED Phase N/A
NCT02105987 A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Status COMPLETED Phase PHASE3
NCT02105974 Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT02105961 Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT02105948 Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE3
NCT02100670 A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain Status COMPLETED Phase PHASE3
NCT02100644 Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study Status COMPLETED Phase PHASE4
NCT02100618 Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study Status WITHDRAWN Phase PHASE3
NCT02097095 Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972) Status COMPLETED Phase N/A
NCT02096263 Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants Status COMPLETED Phase PHASE3
NCT02094937 A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects Status COMPLETED Phase PHASE3
NCT02094924 A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323 Status COMPLETED Phase PHASE1
NCT02094781 Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males Status COMPLETED Phase PHASE1
NCT02082977 A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma Status TERMINATED Phase PHASE1
NCT02082808 Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02082665 Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam Status COMPLETED Phase PHASE1
NCT02082639 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years Status WITHDRAWN Phase PHASE3
NCT02079545 Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants Status COMPLETED Phase PHASE1